Association of low-density lipoprotein particle size and ratio of different lipoproteins and apolipoproteins with coronary heart disease

Journal of Cardiology

Volumn 52, Issue 2, 2008, Pages 118-126

  Biswas, Santanu ^a   Ghoshal, Pradip K ^b   Mandal, Sankar C ^b   Mandal, Nripendranath ^a  

^a BOSE INSTITUTE   (India)

^b NRS MEDICAL COLLEGE   (India)

Author keywords

Apolipoproteins; Coronary heart disease; LDL particle; ROC curve

Indexed keywords

APOLIPOPROTEIN; LOW DENSITY LIPOPROTEIN;

ADULT; AGED; AREA UNDER THE CURVE; ARTICLE; BIOCHEMISTRY; BLOOD SAMPLING; CASE CONTROL STUDY; CLINICAL EVALUATION; CONTROLLED STUDY; FEMALE; HUMAN; INDIA; ISCHEMIC HEART DISEASE; MAJOR CLINICAL STUDY; MALE; MULTIVARIATE LOGISTIC REGRESSION ANALYSIS; POPULATION; RISK FACTOR;

AGED; APOLIPOPROTEINS; APOLIPOPROTEINS B; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, HDL; CORONARY DISEASE; FEMALE; HUMANS; LIPOPROTEINS; LIPOPROTEINS, LDL; MALE; MIDDLE AGED; PARTICLE SIZE; QUESTIONNAIRES;

EID: 52149116474     PISSN: 09145087     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jjcc.2008.06.005     Document Type: Article

References (40)

1. Ailhaud G. In: Angel A., Anderson H., Bouchard C., Lau D., Leiter L., and Mendelson R. (Eds). Adipose cell differentiation: a long way Tipperary (1996), John Libbery & Co. Ltd., London 3-11
2. Lamarshe B., Després J.P., Moorjani S., Cantin B., Degenais G.R., and Lupien J.R. Prevalence of dyslipidemic phenotypes in ischemic heart disease. Am J Cardiol 75 (1995) 1189-1195
3. Enas E.A. Coronary artery disease epidemic in Indians: a cause for alarm and call for action. J Indian Med Assoc 98 (2000) 694-702
4. Reddy K.S. Cardiovascular disease in India. World Health Stat Quart 46 (1993) 101-107
5. Misra A., and Vikram N.K. Insulin resistance syndrome (metabolic syndrome) and Asian Indian. Curr Sci 83 (2002) 1483-1496
6. Stamler J., Daviglus M.L., Garside D.B., Dyer A.R., Greenland P., and Neaton J.D. Relationship of baseline serum cholesterol levels in 3 large cohorts of younger men to long-term coronary, cardiovascular and all cause mortality and to longevity. JAMA 284 (2000) 311-318
7. Srinivasan S.R., Ehnholm C., Wattignecy W.A., Bao W., and Berenson G.S. The relation of apolipoprotein E polymorphism to multiple cardiovascular risks in children: the Bogalusa Heart study. Atherosclerosis 123 (1996) 33-42
8. Wiklund O., Angelin B., Olofsson S.-O., Ericson M., Fager G., Berglund L., et al. Apolipoprotein (a) and ischemic heart disease in familial hypercholesterolemia. Lancet 335 (1990) 1360-1363
9. Satoh H., Nishino T., Tomita K., and Tsutsui H. Fasting triglyceride is a significant risk factor for coronary artery disease in middle aged Japanese man-result from 10 year cohort study. Circ J 70 (2006) 227-231
10. Larmache B., Lemieux I., and Després J.P. The small, dense LDL phenotype and the risk of coronary heart disease: epidemiology, pathophysiology and therapeutic aspects. Diabetes Metab 25 (1999) 199-211
11. Stampfer M.J., Sacks F.M., Salvini S., Willent W.C., and Hennekens C.H. A prospective study of cholesterol, apolipoproteins and the risk of myocardial infarction. N Engl J Med 35 (1991) 373-381
12. Sun Y.H., Yang Y.J., Pei W.D., Wu Y.J., and Gao R.L. Patients with low high-density lipoprotein-cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary artery. Circ J 70 (2006) 1602-1605
13. Chan L. Apolipoprotein B, the major protein component of triglyceride rich and low density lipoproteins. J Biol Chem 267 (1992) 25621-25624
14. Galeano N.F., Al-Haideri M., Keyserman F., Rumsey S.C., and Deckelbaum R.J. Small dense low density lipoprotein has increased affinity for LDL receptor independent cell surface binding sites: a potential mechanism for increased atherogenicity. J Lipid Res 39 (1998) 1263-1273
15. Kondo A., Muranaka Y., Ohta I., Notsu K., Manabe M., Kotani K., et al. Relationship between triglyceride concentration and LDL size evaluated by malondialdehyde-modified LDL. Clin Chem 47 (2001) 893-900
16. Varley H., Gowenlock A.H., and Bell M. Practical clinical biochemistry (1980), William Heinemann Medical Books Ltd., London pp. 625-684
17. Krauss R.M., and Burke D.J. Identification of multiple subclass of plasma low density lipoproteins in normal humans. J Lipid Res 23 (1982) 97-104
18. Matsuzawa Y., Nakamura T., Shimomura I., and Kotani K. In: Angel A., Anderson H., Bouchard C., Lau D., Leiter L., and Mendelson R. (Eds). Visceral fat accumulation and cardiovascular disease (1996), John Liberty & Co., Ltd., London 569-572
19. McInnes G.T. Hypertension and coronary artery disease: cause and effect. J Hypertens 13 (1995) S49-51
20. Siekmeier R., Wülfroth P., Wieland H., Gross W., and März W. Low density lipoprotein susceptibility to in vitro oxidation in healthy smokers and nonsmokers. Clin Chem 42 (1996) 524-530
21. Hozawa A., Folsom A.R., Sharrett A.R., Payne T.J., and Chambless L.E. Does the impact of smoking on coronary heart disease differ by low-density lipoprotein cholesterol level? The Atherosclerosis Risk in Communities (ARIC) Study. Circ J 70 (2006) 1105-1110
22. Carmena R., Lussier-Cacan S., Roy M., Minnic A., Lingenhel A., Kronenberg F., et al. Lp(a) levels and atherosclerotic vascular disease in a sample of patients with familial hypercholesterolemia sharing the same gene defect. Arterioscler Thromb Vasc Biol 16 (1996) 129-136
23. Lewis G.F., and Steiner G. Hypertriglyceridemia and its metabolic consequences as a risk factor for atherosclerotic cardiovascular disease in non-insulin-dependent diabetes mellitus. Diabetes 12 (1996) 36-56
24. Masunaga N., Kimura A., Miyatak M., Nishioka N., Hirano Y., Hayashi T., et al. Effects of alcohol consumption on cardiovascular events in male patients with healed myocardial infarction. Circ J 70 (2006) 1263-1268
25. Gandhi B.M. Lipoprotein composition of normal healthy subjects in Northern India. Indian J Med Res 75 (1982) 393-401
26. Natio H.K. Coronary artery disease & disorders of lipid metabolism. In: Kaplan A., and Pesce A.J. (Eds). Clinical chemistry (1996), Mosby Publishing, St. Louis 642-682
27. Stain E.A., and Myers G.L. Lipids, apolipoproteins and lipoproteins. In: Burtis C.A., and Ashwood E.R. (Eds). Tietz fundamentals of clinical chemistry (1996), WB Saunders Company, Philadelphia 375-401
28. Sun Y.H., Yang Y.J., Pie W.D., Wu Y.J., and Gao R.L. Patients with low high-density lipoprotein cholesterol or smoking are more likely to develop myocardial infarction among subjects with a visible lesion or stenosis in coronary artery. Circ J 70 (2006) 1602-1605
29. Panagiotakos D.B., Pitsavos C., Skoumas J., Chrysohoou C., Toutouza M., Stefanadis C.I., et al. Importance of LDL/HDL cholesterol ratio as a predictor for coronary heart disease events in patients with heterozygous familial hypercholesterolaemia: a 15-year follow-up (1987-2002). Curr Med Res Opin 19 (2003) 89-94
30. Maruyama C., Imamura K., and Teramoto T. Assessment of LDL Particle Size by Triglyceride/HDL Cholesterol Ratio in Non-diabetic Healthy Subjects without Prominent Hyperlipidemia. J Atheroscler Thromb 10 (2003) 186-191
31. Krauss R.M. Heterogenicity of plasma low-density lipoproteins and atherosclerosis risk. Curr Opin Lipidol 5 (1994) 339-349
32. Wagner A.M., Jorba D., Rigla M., Alonso E., Ordonez-Llanos J., and Perez A. LDL cholesterol/apolipoprotein B ratio is a good predictor of LDL phenotype B in type 2 diabetes. Acta Diabetol 39 (2002) 215-220
33. Sniderman A.D., Lamarche B., Tilley J., Secombe D.W., and Forhlich J. Hypertriglyceridemia hyperapo B in type 2 diabetes. Diabetes Care 25 (2002) 579-582
34. Sniderman A.D., Dagenasis G.R., Cantin B., Despres J.P., and Lamarch B. High lipoprotein B with low high density lipoprotein cholesterol and normal plasma triglycerides and cholesterol. Am J Cardiol 87 (2001) 792-793
35. Sniderman A.D., St. Pierre A., Cantin B., Dagenais G.R., Deprés J.P., and Lamarche B. Concordance/discordance between plasma apolipoprotein B levels and the cholesterol indexes of atherosclerotic risk. Am J Cardiol 91 (2003) 1173-1177
36. Enas E.A., and Senthilkumar A. Coronary artery disease in Asian Indians: an update and review. Internet J Cardiol 1 2 (2001)
37. Sniderman A.D., Jungner I., Holme I., Aastveit A., and Walldius G. Errors that result from using the TC/HDL-c ratio rather than the apoB/apoA-I ratio to identify the lipoprotein related risk of vascular disease. J Intern Med 259 (2006) 455-461
38. Sposito A.C., Vinagre C.G., Pandullo F.L., Mies S., Raia S., and Ranires J.A.F. Apolipoprotein and lipid abnormalities in chronic liver failure. Braz J Med Biol Res 30 (1997) 1287-1290
39. Luepker R.V., Apple F.S., Christenson R.H., Crow R.S., Fortmann S.P., Goff D., et al. Case definitions for acute coronary heart disease in epidemiology and clinical research studies: a statement from the AHA Council on Epidemiology and Prevention; AHA Statistics Committee; World Heart Federation Council on Epidemiology and Prevention; the European Society of Cardiology Working Group on Epidemiology and Prevention; Centers for Disease Control and Prevention; and the National Heart, Lung, and Blood Institute. Circulation 108 (2003) 2543-2549
40. Hamm C.W., and Braunwald E. A classification of unstable angina revisited. Circulation 102 (2000) 118-122